Zinc Gluconate Sprays Challenged In Lawsuits; Matrixx Defends Zicam Safety
This article was originally published in The Tan Sheet
Executive Summary
The safety of zinc gluconate sprays has been called into question by a recent spate of lawsuits alleging that the products cause users to lose their sense of smell
You may also be interested in...
Zicam Sales Up, Matrixx Cuts Loss With Legal Expenses Down More Than Half
High sales of Matrixx Initiatives' Zicam line in an out-of-season quarter helped the OTC manufacturer increase cold and cough product sales, the firm said
Matrixx settles Zicam suits
Matrixx has reached a settlement agreement intended to end 90% of the product liability litigation related to the firm's ZicamCold Remedy Nasal Gel, the company announces Jan. 19. The suits, filed in April 2004 in Arizona state court, involve approximately 340 plaintiffs who allege that use of the cold product caused them to lose their sense of smell. As a result of the settlement, the plaintiffs will dismiss their case with prejudice in return for an undisclosed sum of money. The individual amounts will be determined by medical protocol, Matrixx adds. The firm expects to pay a total of $12 mil. to fund the program; in order to go ahead with the settlement, 95% of the plaintiffs must accept the terms within two months, according to the firm. The company will "continue to fight" related litigation in Alabama and Colorado, a company spokesperson said (1"The Tan Sheet" Nov. 13, 2004, p. 13)...
Matrixx Eyes Antacids, Oral Care; Zicam Brand Drives 50% Sales Jump
Matrixx is concentrating research spending on antacids, analgesics and oral care as possible areas for new product development